Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ACRX

AcelRX Pharmaceuticals (ACRX)

AcelRX Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACRX
DateTimeSourceHeadlineSymbolCompany
12/13/20123:14PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/13/20123:07PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/13/20123:07PMEdgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/11/20123:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/11/20123:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/07/20125:11PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/07/20125:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/07/20125:05PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/07/20126:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/07/20126:01AMEdgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/06/201210:08PMPR Newswire (US)AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common StockNASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/05/20126:12AMEdgar (US Regulatory)Securities Registration Statement (S-1/A)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/05/20126:12AMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/05/20126:00AMPR Newswire (US)AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common StockNASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/20/20127:41PMPR Newswire (US)AcelRx Pharmaceuticals to Present at the Piper Jaffray 24th Annual Healthcare ConferenceNASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/20/20124:40PMEdgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/15/20124:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/15/20124:10PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/15/20127:00AMPR Newswire (US)AcelRx Announces Primary Endpoint Met in Phase 3 Non-Inferiority Study of Sublingual Sufentanil NanoTabĀ® PCA System vs. IV P...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/14/20127:43PMPR Newswire (US)AcelRx Announces Achievement of the Primary End-Point in Phase 3 Comparative Study Involving the Sufentanil NanoTab PCA Syste...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/06/20125:04PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/06/20125:04PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/06/20124:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/06/20124:32PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/06/20124:10PMPR Newswire (US)AcelRx Pharmaceuticals Reports Third Quarter 2012 Financial ResultsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/05/20127:30AMPR Newswire (US)AcelRx Pharmaceuticals Doses the First Patients in ARX-04 Phase 2 Clinical StudyNASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/01/20127:30AMPR Newswire (US)AcelRx Pharmaceuticals to Hold Third Quarter 2012 Financial Results Conference Call and Webcast on November 6, 2012NASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/03/20127:30AMPR Newswire (US)AcelRx Receives Notice of Eligibility for Centralized Review from European Medicines Agency for the Sufentanil NanoTabĀ® PCA ...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/18/20127:30AMPR Newswire (US)AcelRx Pharmaceuticals Hires Mike A. Royal, M.D. as Chief, Clinical AffairsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/10/20127:30AMPR Newswire (US)AcelRx Pharmaceuticals to Present at the UBS Global Life Sciences ConferenceNASDAQ:ACRXAcelRX Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACRX

Your Recent History

Delayed Upgrade Clock